Undifferentiated Carcinoma
3 clinical trials · Condition
◉ Watch Undifferentiated Carcinoma
| Record | Firm | Date |
|---|---|---|
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00565851) | National Cancer Institute (NCI) | 2007-12-06 |
| Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck (NCT00570674) | Dana-Farber Cancer Institute | 2007-11-01 |
Track Undifferentiated Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.